|
Search
Collections
Benchmarks
Upload document
GPI-IL-12
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 abstract
Abstract
Feasibility study of a personalized tumor membrane vesicle vaccine immunotherapy for head and neck squamous cell carcinoma (HNSCC).
Org:
Metaclipse Therapeutics Corporation,
